Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling

Published:2019-03 Issue: Volume:56 Page:126-135
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Dai Guoliang,Sun Bingting,Gong Tao,Pan Zihao,Meng Qinghai,Ju Wenzheng

Funder

National Natural Science Foundation of China

Medical Technology Development Foundation of Nanjing China

Postdoctoral scientific research Foundation

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference31 articles.

1. Ginseng pharmacology: multiple constituents and multiple actions;Attele;Biochem. Pharmacol.,1999

2. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression;Biswas;J. Clin. Invest.,2007

3. Panax ginseng: a role in cancer therapy?;Chang;Integr. Cancer Ther.,2003

4. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway;Cong;Biomed. Pharmacother.,2017

5. Colorectal cancer;Cunningham;Lancet,2010

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in nano and micro formulations of Ginsenoside to enhance their therapeutic efficacy;Phytomedicine;2024-11

2. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance;Biomedicine & Pharmacotherapy;2024-08

3. Traditional Chinese Medicine JianPiHuaTan formula improving quality of life and survival in patients with colorectal cancer through RAS/RAF downstream signaling pathways;Frontiers in Pharmacology;2024-06-20

4. Ginsenosides: an immunomodulator for the treatment of colorectal cancer;Frontiers in Pharmacology;2024-06-12

5. TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer;Medical Oncology;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3